1.
Int J Rad Appl Instrum B
; 13(2): 227-30, 1986.
Article
in English
| MEDLINE
| ID: mdl-3771253
Subject(s)
Malpractice , Nuclear Medicine , Pharmacy , Radioisotopes/adverse effects , France , Humans , Radioisotopes/therapeutic use
2.
Ann Pharm Fr
; 40(1): 29-32, 1982 Apr.
Article
in French
| MEDLINE
| ID: mdl-7103358
3.
Ann Pharm Fr
; 38(1): 55-9, 1980.
Article
in French
| MEDLINE
| ID: mdl-7396340
4.
IARC Sci Publ (1971)
; (25): 129-49, 1979.
Article
in English
| MEDLINE
| ID: mdl-457149
ABSTRACT
The pharmaceutical industry is perhaps most subject to rules and regulations in the majority of countries. Legislation in France in this regard is flexible and relatively easily adaptable; in addition, the pharmaceutical industry has established its own ground rules. One of these requires that a product be harmless under normal conditions of use; carcinogenicity checks are only mandatory under certain conditions. If they were to be made compulsory, a less unwieldy test system would be required. The use to which a product is put should be taken into consideration in regulating it.
Subject(s)
Carcinogens , Drug Industry , Neoplasms/etiology , Aerosols , Aflatoxins/adverse effects , Asbestos/adverse effects , Carcinogens/analysis , Coloring Agents/adverse effects , Cosmetics/analysis , Cyclamates/adverse effects , Drug Packaging , Food Coloring Agents/adverse effects , Humans , Neoplasms/chemically induced , Polyvinyl Chloride/adverse effects , Saccharin/adverse effects , Sweetening Agents/adverse effects , Vinyl Chloride/adverse effects
5.
Therapie
; 29(1): 51-56, 1974.
Article
in French
| MEDLINE
| ID: mdl-4849524
6.
Ann Chir Thorac Cardiovasc
; 7(2): 539-41, 1968 Apr.
Article
in French
| MEDLINE
| ID: mdl-5758336
